503 related articles for article (PubMed ID: 3156149)
21. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
Teng CM; Chen YH; Ouyang C
Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet effect of butylidenephthalide.
Teng CM; Chen WY; Ko WC; Ouyang CH
Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
[TBL] [Abstract][Full Text] [Related]
23. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid.
Aharony D; Smith JB; Silver MJ
Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496
[TBL] [Abstract][Full Text] [Related]
24. XC 386: a new antiplatelet agent.
Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
[TBL] [Abstract][Full Text] [Related]
25. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
26. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
27. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
29. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
[TBL] [Abstract][Full Text] [Related]
31. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
32. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
[TBL] [Abstract][Full Text] [Related]
33. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
Lösche W; Michel E; Thielmann K; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
[TBL] [Abstract][Full Text] [Related]
34. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
Zucker MB; Mauss EA
Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
[TBL] [Abstract][Full Text] [Related]
35. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
Raz A
Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
[TBL] [Abstract][Full Text] [Related]
36. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
Schafer AI; Zavoico GB; Loscalzo J; Maas AK
Blood; 1987 May; 69(5):1504-7. PubMed ID: 3032310
[TBL] [Abstract][Full Text] [Related]
37. Nonreceptor interactions in the pharmacology of blood platelets.
Nosál R; Jancinová V
Gen Physiol Biophys; 1999 Oct; 18 Spec No():120-5. PubMed ID: 10703730
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
Sato T; Nakao K; Hashizume T; Fujii T
Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
[TBL] [Abstract][Full Text] [Related]
39. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
Bernstrom K; Malcolm K; McGee J; Maclouf J; Levy-Toledano S; Falck JR; Fitzpatrick FA
Mol Pharmacol; 1991 Feb; 39(2):114-9. PubMed ID: 1847490
[TBL] [Abstract][Full Text] [Related]
40. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
